Apolipoprotein(a) enhances platelet responses to the thrombin receptor- activating peptide SFLLRN

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 9, 1998, Pages 1393-1399

  Rand, Margaret L ^a,d   Sangrar, Waheed ^b   Hancock, Mark A ^b   Taylor, Desirée M ^a   Marcovina, Santica M ^c   Packham, Marian A ^a   Koschinsky, Marlys L ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apolipoprotein(a); Lipoprotein(a); Platelet function; SFLLRN; Thrombin receptor activating peptide

Indexed keywords

APOLIPOPROTEIN A1; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM;

EID: 0031713182     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.9.1393     Document Type: Article

References (25)

1. Durrington PN. Lipoprotein(a). Ballieres Clin Endocrinol Metab. 1995;9:773-779.
2. Koschinsky ML, Marcovina SM. Lipoprotein(a): structural implications for pathophysiology. Int J Clin Lab Res. 1997;27:14-23.
3. Koschinsky ML, Ramharack R. Structure and metabolism of lipoprotein(a). Curr Pharmacol Design. 1996;2:121-138.
4. Koschinsky ML, Côté GP, Gabel B, van der Hoek YY. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoproteinB-100. J Biol Chem. 1993;268:19819-19825.
5. Brunner C, Kraft H-G, Utermann G, Muller H-J. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A. 1993;90:11643-11647.
6. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132-137.
7. van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein JJP, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet. 1993;2:361-366.
8. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993;2:933-940.
9. Sangrar W, Marcovina SM, Koschinsky ML. Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. Protein Eng. 1994;7:723-731.
10. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989;86:3847-3851.
11. Loscalzo J, Weinfield M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis. 1990;10:240-245.
12. Rouy D, Koschinsky ML, Fleury V, Chapman J, Angles-Cano E. The binding of human recombinant apolipoprotein(a) and plasminogen to fibrin surfaces. Biochemistry. 1992;3:6333-6339.
13. Sangrar W, Bajzar L, Nesheim ME, Koschinsky ML. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation. Biochemistry. 1995;34:5151-5157.
14. Ezratty A, Simon DI, Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 1993;32:4628-4633.
15. Malle E, Ibovnik A, Steinmetz A, Kostner GH, Sattler W. Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Arterioscler Thromb Vase Biol. 1994;14:345-352.
16. Gries A, Gries M, Wurm H, Kenner T, Ijsseldijk M, Sixma JJ, Kostner GM. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler Thromb Vase Biol. 1996;16:648-655.
17. 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets. Arterioscler Thromb Vase Biol. 1997;17:156-163.
18. Aviram M, Brook JG. Platelet interaction with high and low density lipoproteins. Atherosclerosis. 1983;46:259-268.
19. Malle E, Sattler W. Platelets and the lipoproteins: native, modified and platelet modified lipoproteins. Platelets. 1994;5:70-83.
20. Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 1993;72:278-284.
21. Gabel BR, May LF, Marcovina SM, Koschinsky ML. Lipoprotein(a) assembly: quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. Arterioscler Thromb Vasc Biol. 1996;16:1559-1567.
22. Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Apolipoprotein(a) expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 1991;30:5044-5051.
23. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977:36:59-77.
24. Gorman C, Padmanahban R, Howard R. High efficiency DNA-mediated transformation of primate cells. Science. 1983;221:551-553.
25. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus IV DNA. Virology. 1973;52:456-467.